+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mood Stabilizer"

From
Olanzapine Market Report 2025 - Product Thumbnail Image

Olanzapine Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Post-Traumatic Stress Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bipolar Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
From
Bipolar Disorder (Manic Depression) - Pipeline Insight, 2024 - Product Thumbnail Image

Bipolar Disorder (Manic Depression) - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 80 Pages
  • Global
From
Schizoaffective Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Schizoaffective Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Schizophrenia Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Schizophrenia Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Bipolar Disorder Therapeutics Market 2024-2028 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 161 Pages
  • Global
From
Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 Pages
  • Global
From
Loading Indicator

Mood stabilizers are a class of drugs used to treat mental disorders, such as bipolar disorder, depression, and anxiety. These drugs work by regulating the levels of neurotransmitters in the brain, which can help to reduce the intensity of mood swings and other symptoms associated with mental disorders. Commonly prescribed mood stabilizers include lithium, valproic acid, carbamazepine, and lamotrigine. Mood stabilizers are an important part of the mental disorders drugs market, as they can help to reduce the severity of symptoms and improve quality of life for those affected. They are often used in combination with other medications, such as antidepressants, to provide a comprehensive treatment plan. Some of the companies in the mood stabilizer market include AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more